Jaffetilchin Investment Partners, LLC Humacyte, Inc. Transaction History
Jaffetilchin Investment Partners, LLC
- $1.35 Billion
- Q4 2024
A detailed history of Jaffetilchin Investment Partners, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 67,200 shares of HUMA stock, worth $204,288. This represents 0.03% of its overall portfolio holdings.
Number of Shares
67,200Holding current value
$204,288% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
172Shares Held
41MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$17 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$14 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$8.66 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$6.49 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $313M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...